CRLBF
Cresco Labs Inc.
Price Chart
Latest Quote
$0.80
-0.00 (-0.14%)
Current Price
| Previous Close | $0.80 |
| Open | $0.80 |
| Day High | $0.81 |
| Day Low | $0.80 |
| Volume | 37,352 |
Stock Information
| Shares Outstanding | 354.23M |
| Total Debt | $586.78M |
| Cash Equivalents | $32.34M |
| Revenue | $641.41M |
| Net Income | $-134.05M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $296.40M |
| EPS (TTM) | $-0.38 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $766.80M |
| Sales | $641.41M |
| Income | $-134.05M |
| Book/sh | $0.91 |
| Cash/sh | $0.09 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 0.72 |
| Current Ratio | 2.51 |
| Debt/Eq | 240.28 |
Returns & Margins
| ROA | 3.64% |
| ROE | -45.77% |
| Gross Margin | 50.11% |
| Operating Margin | 7.38% |
| Profit Margin | -20.90% |
Ownership
| Insider Ownership | 2.06% |
| Institutional Ownership | 3.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -13.16 |
| P/S | 0.46 |
| P/B | 0.88 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $2.00 |
Technical Indicators
| SMA20 | $0.88 |
| SMA50 | $0.95 |
| SMA200 | $1.06 |
| RSI | 33.61 |
| ATR | 0.0686 |
| Shares Float | 309.59M |
| Volatility | 1.71 |
| Rel Volume | 0.07 |
Performance History
| Week | -5.88% |
| Month | -2.56% |
| Quarter | -20.79% |
| 6 Months | -54.39% |
| YTD | -36.51% |
| Year | +68.78% |
| 3 Years | -50.00% |
| 5 Years | -93.03% |
| 10 Years | -83.88% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.80 | 37,352 |
| 2026-06-17 | $0.80 | 390,900 |
| 2026-06-16 | $0.82 | 487,400 |
| 2026-06-15 | $0.82 | 338,800 |
| 2026-06-12 | $0.82 | 712,200 |
| 2026-06-11 | $0.85 | 450,200 |
| 2026-06-10 | $0.88 | 260,800 |
| 2026-06-09 | $0.90 | 778,200 |
| 2026-06-08 | $0.95 | 859,300 |
| 2026-06-05 | $0.90 | 1,700,600 |
| 2026-06-04 | $0.91 | 556,000 |
| 2026-06-03 | $0.87 | 732,300 |
| 2026-06-02 | $0.91 | 297,800 |
| 2026-06-01 | $0.95 | 476,700 |
| 2026-05-29 | $0.92 | 438,400 |
| 2026-05-28 | $0.96 | 634,300 |
| 2026-05-27 | $0.90 | 330,300 |
| 2026-05-26 | $0.91 | 878,800 |
| 2026-05-22 | $0.86 | 363,100 |
| 2026-05-21 | $0.91 | 567,900 |
| 2026-05-20 | $0.88 | 411,700 |
| 2026-05-19 | $0.82 | 590,000 |
| 2026-05-18 | $0.89 | 638,500 |
About Cresco Labs Inc.
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
đ° Latest News
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
Zacks âĸ 2026-06-18T12:28:00Z
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
Zacks âĸ 2026-06-11T12:12:00Z
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
MT Newswires âĸ 2026-06-08T11:27:44ZCresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
Zacks âĸ 2026-05-11T16:00:06Z
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-08T12:05:01Z
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
Zacks âĸ 2026-05-07T21:55:06Z
Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors
Zacks âĸ 2026-05-06T12:55:01Z
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-05T22:05:16Z
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive âĸ 2026-04-13T14:39:10ZWhy The Narrative Around Cresco Labs (CNSX:CL) Is Shifting After Trimmed Price Target
Simply Wall St. âĸ 2026-04-06T01:13:13Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $315,666,000 | $363,753,000 | $435,668,000 | $415,335,000 |
| Cost Of Revenue | $359,889,000 | $408,519,000 | $435,668,000 | $415,335,000 |
| Total Revenue | $724,343,000 | $770,885,000 | $842,681,000 | $821,682,000 |
| Operating Revenue | $724,343,000 | $770,885,000 | $842,681,000 | $821,682,000 |
| Expenses | ||||
| Interest Expense | $58,901,000 | $63,623,000 | $58,516,000 | $52,149,000 |
| Total Expenses | $614,261,000 | $708,005,000 | $785,749,000 | $733,892,000 |
| Rent Expense Supplemental | $27,980,000 | $28,015,000 | - | - |
| Other Income Expense | $-64,719,000 | $-148,963,000 | $-126,000,000 | $-293,306,000 |
| Other Non Operating Income Expenses | $-63,205,000 | $832,000 | $3,260,000 | $-395,000 |
| Net Non Operating Interest Income Expense | $-55,979,000 | $-60,819,000 | $-57,837,000 | $-51,211,000 |
| Interest Expense Non Operating | $58,901,000 | $63,623,000 | $58,516,000 | $52,149,000 |
| Operating Expense | $254,372,000 | $299,486,000 | $350,081,000 | $318,557,000 |
| General And Administrative Expense | $232,272,000 | $274,634,000 | - | - |
| Other Operating Expenses | - | $314,000 | $-572,000 | $753,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-74,438,000 | $-175,522,000 | $-212,047,000 | $-319,597,000 |
| Net Interest Income | $-55,979,000 | $-60,819,000 | $-57,837,000 | $-51,211,000 |
| Interest Income | $2,922,000 | $2,804,000 | $679,000 | $938,000 |
| Normalized Income | $-73,241,940 | $-57,183,950 | $-109,931,600 | $-106,645,050 |
| Net Income From Continuing And Discontinued Operation | $-74,438,000 | $-175,522,000 | $-212,047,000 | $-319,597,000 |
| Total Operating Income As Reported | $107,292,000 | $-87,823,000 | $-84,295,000 | $-217,351,000 |
| Net Income Common Stockholders | $-74,438,000 | $-175,522,000 | $-212,047,000 | $-319,597,000 |
| Net Income | $-74,438,000 | $-175,522,000 | $-212,047,000 | $-319,597,000 |
| Net Income Including Noncontrolling Interests | $-60,489,000 | $-179,852,000 | $-215,843,000 | $-296,834,000 |
| Net Income Continuous Operations | $-60,489,000 | $-179,852,000 | $-215,843,000 | $-296,834,000 |
| Pretax Income | $-10,616,000 | $-146,902,000 | $-126,905,000 | $-256,727,000 |
| Special Income Charges | $-2,481,000 | $-148,992,000 | $-121,068,000 | $-323,930,000 |
| Interest Income Non Operating | $2,922,000 | $2,804,000 | $679,000 | $938,000 |
| Operating Income | $110,082,000 | $62,880,000 | $56,932,000 | $87,790,000 |
| Depreciation Amortization Depletion Income Statement | $21,770,000 | $24,538,000 | - | - |
| Depreciation And Amortization In Income Statement | $21,770,000 | $24,538,000 | - | - |
| Amortization Of Intangibles Income Statement | $3,861,000 | $3,699,000 | - | - |
| Depreciation Income Statement | $17,909,000 | $20,839,000 | - | - |
| Gross Profit | $364,454,000 | $362,366,000 | $407,013,000 | $406,347,000 |
| Earnings From Equity Interest | - | - | $0 | $-1,196,000 |
| Per Share | ||||
| Diluted EPS | $-0.17 | $-0.53 | $-0.71 | $-1.22 |
| Basic EPS | $-0.17 | $-0.53 | $-0.71 | $-1.22 |
| Other | ||||
| Tax Effect Of Unusual Items | $-317,940 | $-31,456,950 | $-27,144,600 | $-78,763,050 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $115,792,000 | $135,820,000 | $118,596,000 | $132,086,000 |
| Total Unusual Items | $-1,514,000 | $-149,795,000 | $-129,260,000 | $-291,715,000 |
| Total Unusual Items Excluding Goodwill | $-1,514,000 | $-149,795,000 | $-129,260,000 | $-291,715,000 |
| Reconciled Depreciation | $65,993,000 | $69,304,000 | $57,725,000 | $44,949,000 |
| EBITDA (Bullshit earnings) | $114,278,000 | $-13,975,000 | $-10,664,000 | $-159,629,000 |
| EBIT | $48,285,000 | $-83,279,000 | $-68,389,000 | $-204,578,000 |
| Diluted Average Shares | $348,598,547 | $339,708,308 | $298,161,665 | $262,326,138 |
| Basic Average Shares | $348,598,547 | $339,708,308 | $298,161,665 | $262,326,138 |
| Diluted NI Availto Com Stockholders | $-74,438,000 | $-175,522,000 | $-212,047,000 | $-319,597,000 |
| Minority Interests | $-13,949,000 | $4,330,000 | $3,796,000 | $-22,763,000 |
| Tax Provision | $49,873,000 | $32,950,000 | $88,938,000 | $40,107,000 |
| Gain On Sale Of Ppe | $-683,000 | $762,000 | $14,711,000 | $-6,000 |
| Gain On Sale Of Business | $125,000 | $0 | - | - |
| Other Special Charges | $-599,000 | $-1,263,000 | $-4,876,000 | $18,030,000 |
| Write Off | $2,320,000 | $151,017,000 | $140,655,000 | $305,894,000 |
| Restructuring And Mergern Acquisition | $202,000 | $0 | - | - |
| Gain On Sale Of Security | $967,000 | $-803,000 | $-8,192,000 | $32,215,000 |
| Provision For Doubtful Accounts | $330,000 | $314,000 | $-572,000 | $753,000 |
| Amortization | $3,861,000 | $3,699,000 | - | - |
| Selling General And Administration | $232,272,000 | $274,634,000 | $350,653,000 | $317,804,000 |
| Other Gand A | $207,826,000 | $249,187,000 | - | - |
| Rent And Landing Fees | $12,643,000 | $12,523,000 | - | - |
| Salaries And Wages | $11,803,000 | $12,924,000 | - | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-102,624,000 | $-70,971,000 | $-111,106,000 | $-128,857,000 |
| Total Assets | $1,355,355,000 | $1,358,467,000 | $1,583,692,000 | $1,780,463,000 |
| Total Non Current Assets | $1,061,098,000 | $1,080,380,000 | $1,257,646,000 | $1,358,708,000 |
| Other Non Current Assets | $14,990,000 | $5,980,000 | $9,438,000 | $4,210,000 |
| Non Current Deferred Assets | $13,127,000 | $11,547,000 | $26,000 | $6,561,000 |
| Non Current Deferred Taxes Assets | $13,127,000 | $11,547,000 | $26,000 | $6,561,000 |
| Goodwill And Other Intangible Assets | $577,478,000 | $576,663,000 | $738,145,000 | $884,411,000 |
| Other Intangible Assets | $293,994,000 | $296,966,000 | $407,590,000 | $437,644,000 |
| Current Assets | $294,257,000 | $278,087,000 | $326,046,000 | $421,755,000 |
| Other Current Assets | $2,228,000 | $4,291,000 | $3,569,000 | $3,654,000 |
| Restricted Cash | $3,439,000 | $5,091,000 | $2,169,000 | $2,559,000 |
| Prepaid Assets | $16,120,000 | $6,417,000 | $9,420,000 | $10,665,000 |
| Inventory | $83,343,000 | $107,789,000 | $134,608,000 | $136,643,000 |
| Receivables | $51,563,000 | $51,070,000 | $56,939,000 | $44,691,000 |
| Accounts Receivable | $51,563,000 | $51,070,000 | $56,492,000 | $43,379,000 |
| Allowance For Doubtful Accounts Receivable | $-8,308,000 | $-7,964,000 | $-2,627,000 | $-2,220,000 |
| Gross Accounts Receivable | $59,871,000 | $59,034,000 | $59,119,000 | $45,599,000 |
| Cash Cash Equivalents And Short Term Investments | $137,564,000 | $103,429,000 | $119,341,000 | $223,543,000 |
| Cash And Cash Equivalents | $137,564,000 | $103,429,000 | $119,341,000 | $223,543,000 |
| Non Current Note Receivables | - | $826,000 | $823,000 | $505,000 |
| Investmentin Financial Assets | - | $681,000 | $1,092,000 | $1,202,000 |
| Loans Receivable | - | $1,421,000 | $447,000 | $1,312,000 |
| Debt | ||||
| Net Debt | $332,511,000 | $404,097,000 | $367,050,000 | $251,247,000 |
| Total Debt | $639,641,000 | $682,757,000 | $670,171,000 | $624,735,000 |
| Long Term Debt And Capital Lease Obligation | $616,084,000 | $661,524,000 | $650,236,000 | $584,015,000 |
| Long Term Debt | $460,750,000 | $497,713,000 | $476,891,000 | $465,079,000 |
| Current Debt And Capital Lease Obligation | $23,557,000 | $21,233,000 | $19,935,000 | $40,720,000 |
| Current Debt | $9,325,000 | $9,813,000 | $9,500,000 | $9,711,000 |
| Other Current Borrowings | $9,325,000 | $9,813,000 | $9,500,000 | $9,711,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $967,179,000 | $930,400,000 | $996,009,000 | $982,727,000 |
| Total Non Current Liabilities Net Minority Interest | $872,841,000 | $730,158,000 | $740,144,000 | $694,333,000 |
| Other Non Current Liabilities | $87,603,000 | $21,600,000 | $7,000,000 | $7,001,000 |
| Tradeand Other Payables Non Current | $122,468,000 | $0 | - | - |
| Non Current Deferred Liabilities | $46,686,000 | $47,034,000 | $82,908,000 | $103,317,000 |
| Non Current Deferred Taxes Liabilities | $38,950,000 | $40,457,000 | $75,138,000 | $85,666,000 |
| Current Liabilities | $94,338,000 | $200,242,000 | $255,865,000 | $288,394,000 |
| Current Deferred Liabilities | $2,486,000 | $0 | $47,834,000 | $71,833,000 |
| Payables And Accrued Expenses | $68,295,000 | $179,009,000 | $188,096,000 | $174,669,000 |
| Payables | $13,999,000 | $109,930,000 | $122,935,000 | $79,227,000 |
| Total Tax Payable | $348,000 | $82,343,000 | $94,842,000 | $46,949,000 |
| Income Tax Payable | $348,000 | $82,343,000 | $94,842,000 | $46,949,000 |
| Accounts Payable | $13,651,000 | $27,587,000 | $28,093,000 | $32,278,000 |
| Other Current Liabilities | - | - | - | $1,172,000 |
| Equity | ||||
| Common Stock Equity | $474,854,000 | $505,692,000 | $627,039,000 | $755,554,000 |
| Total Equity Gross Minority Interest | $388,176,000 | $428,067,000 | $587,683,000 | $797,736,000 |
| Stockholders Equity | $474,854,000 | $505,692,000 | $627,039,000 | $755,554,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,232,000 | $-1,151,000 | $-1,393,000 | $-254,000 |
| Other Equity Adjustments | $-2,232,000 | $-1,151,000 | $-1,393,000 | $-254,000 |
| Retained Earnings | $-1,352,486,000 | $-1,265,536,000 | $-1,076,198,000 | $-841,907,000 |
| Other | ||||
| Ordinary Shares Number | $348,598,547 | $339,708,308 | $301,230,986 | $290,701,470 |
| Share Issued | $348,598,547 | $339,708,308 | $301,230,986 | $290,701,470 |
| Tangible Book Value | $-102,624,000 | $-70,971,000 | $-111,106,000 | $-128,857,000 |
| Invested Capital | $944,929,000 | $1,013,218,000 | $1,113,430,000 | $1,230,344,000 |
| Working Capital | $199,919,000 | $77,845,000 | $70,181,000 | $133,361,000 |
| Capital Lease Obligations | $169,566,000 | $175,231,000 | $183,780,000 | $149,945,000 |
| Total Capitalization | $935,604,000 | $1,003,405,000 | $1,103,930,000 | $1,220,633,000 |
| Minority Interest | $-86,678,000 | $-77,625,000 | $-39,356,000 | $42,182,000 |
| Additional Paid In Capital | $122,750,000 | $82,927,000 | $87,537,000 | - |
| Capital Stock | $1,706,822,000 | $1,689,452,000 | $1,617,093,000 | $1,597,715,000 |
| Common Stock | $1,706,822,000 | $1,689,452,000 | $1,617,093,000 | $1,597,715,000 |
| Long Term Capital Lease Obligation | $155,334,000 | $163,811,000 | $173,345,000 | $118,936,000 |
| Current Capital Lease Obligation | $14,232,000 | $11,420,000 | $10,435,000 | $31,009,000 |
| Current Accrued Expenses | $54,296,000 | $69,079,000 | $65,161,000 | $95,442,000 |
| Goodwill | $283,484,000 | $279,697,000 | $330,555,000 | $446,767,000 |
| Net PPE | $455,503,000 | $486,190,000 | $507,986,000 | $457,109,000 |
| Accumulated Depreciation | $-162,419,000 | $-120,839,000 | $-77,695,000 | $-50,018,000 |
| Gross PPE | $617,922,000 | $607,029,000 | $585,681,000 | $507,127,000 |
| Leases | $183,522,000 | $173,614,000 | $142,880,000 | $152,778,000 |
| Construction In Progress | $12,037,000 | $14,483,000 | $55,507,000 | $42,847,000 |
| Other Properties | $110,657,000 | $117,882,000 | $128,264,000 | $88,017,000 |
| Machinery Furniture Equipment | $102,038,000 | $93,856,000 | $82,436,000 | $76,601,000 |
| Land And Improvements | $209,668,000 | $207,194,000 | $176,594,000 | $146,884,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $24,317,000 | $25,665,000 | $30,502,000 | $49,204,000 |
| Work In Process | $33,803,000 | $51,538,000 | $41,164,000 | $26,561,000 |
| Raw Materials | $25,223,000 | $30,586,000 | $62,942,000 | $60,878,000 |
| Investments And Advances | - | $730,000 | $1,228,000 | $5,912,000 |
| Other Investments | - | $49,000 | $136,000 | $4,710,000 |
| Available For Sale Securities | - | $681,000 | $1,092,000 | $1,202,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $108,994,000 | $681,000 | $-67,391,000 | $-82,566,000 |
| Operating Activities | ||||
| Operating Cash Flow | $132,480,000 | $58,564,000 | $18,741,000 | $14,487,000 |
| Cash Flow From Continuing Operating Activities | $132,480,000 | $58,564,000 | $18,741,000 | $14,487,000 |
| Operating Gains Losses | $718,000 | $790,000 | $5,126,000 | $-6,521,000 |
| Investing Activities | ||||
| Capital Expenditure | $-23,486,000 | $-57,883,000 | $-86,132,000 | $-97,053,000 |
| Investing Cash Flow | $-25,229,000 | $-44,585,000 | $-36,577,000 | $-163,933,000 |
| Cash Flow From Continuing Investing Activities | $-25,229,000 | $-44,585,000 | $-36,577,000 | $-163,933,000 |
| Net Other Investing Changes | $1,055,000 | $1,594,000 | $2,776,000 | $-24,292,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-200,000 | $0 | - | - |
| Financing Cash Flow | $-71,478,000 | $-26,907,000 | $-86,643,000 | $235,005,000 |
| Cash Flow From Continuing Financing Activities | $-71,478,000 | $-26,907,000 | $-86,643,000 | $235,005,000 |
| Net Other Financing Charges | $-27,503,000 | $-43,597,000 | $-87,432,000 | $-69,946,000 |
| Net Common Stock Issuance | $-200,000 | $0 | $0 | $124,105,000 |
| Issuance Of Capital Stock | - | - | $0 | $124,105,000 |
| Common Stock Issuance | - | - | $0 | $124,105,000 |
| Other | ||||
| Repayment Of Debt | $-43,784,000 | $-3,485,000 | $-2,426,000 | $-226,250,000 |
| Issuance Of Debt | $0 | $20,175,000 | $0 | $387,000,000 |
| Interest Paid Supplemental Data | $55,196,000 | $53,616,000 | $53,651,000 | $39,118,000 |
| Income Tax Paid Supplemental Data | $9,195,000 | $70,896,000 | $46,756,000 | $73,955,000 |
| End Cash Position | $144,254,000 | $108,520,000 | $121,510,000 | $226,102,000 |
| Beginning Cash Position | $108,520,000 | $121,510,000 | $226,102,000 | $140,774,000 |
| Effect Of Exchange Rate Changes | $-39,000 | $-62,000 | $-113,000 | $-231,000 |
| Changes In Cash | $35,773,000 | $-12,928,000 | $-104,479,000 | $85,559,000 |
| Proceeds From Stock Option Exercised | $9,000 | $0 | $3,215,000 | $20,096,000 |
| Common Stock Payments | $-200,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-43,784,000 | $16,690,000 | $-2,426,000 | $160,750,000 |
| Net Long Term Debt Issuance | $-43,784,000 | $16,690,000 | $-2,426,000 | $160,750,000 |
| Long Term Debt Payments | $-43,784,000 | $-3,485,000 | $-2,426,000 | $-226,250,000 |
| Long Term Debt Issuance | $0 | $20,175,000 | $0 | $387,000,000 |
| Net Business Purchase And Sale | $-3,230,000 | $0 | $-1,135,000 | $-75,745,000 |
| Purchase Of Business | $-3,230,000 | $0 | $-1,135,000 | $-75,814,000 |
| Net Intangibles Purchase And Sale | $-3,994,000 | $-2,498,000 | $-3,106,000 | $-3,178,000 |
| Purchase Of Intangibles | $-3,994,000 | $-2,498,000 | $-3,106,000 | $-3,178,000 |
| Net PPE Purchase And Sale | $-19,060,000 | $-43,681,000 | $-35,112,000 | $-60,718,000 |
| Sale Of PPE | $432,000 | $11,704,000 | $47,914,000 | $33,157,000 |
| Purchase Of PPE | $-19,492,000 | $-55,385,000 | $-83,026,000 | $-93,875,000 |
| Change In Working Capital | $36,343,000 | $15,218,000 | $13,454,000 | $-29,069,000 |
| Change In Other Current Liabilities | $-7,902,000 | $-28,002,000 | $-22,073,000 | $-16,526,000 |
| Change In Payables And Accrued Expense | $24,934,000 | $22,500,000 | $57,483,000 | $23,056,000 |
| Change In Payable | $24,934,000 | $22,500,000 | $57,483,000 | $23,056,000 |
| Change In Account Payable | $-15,539,000 | $27,795,000 | $10,700,000 | $21,155,000 |
| Change In Tax Payable | $40,473,000 | $-5,295,000 | $46,783,000 | $1,901,000 |
| Change In Income Tax Payable | $40,473,000 | $-5,295,000 | $46,783,000 | $1,901,000 |
| Change In Prepaid Assets | $2,486,000 | $2,598,000 | $-4,512,000 | - |
| Change In Inventory | $18,556,000 | $23,491,000 | $-2,668,000 | $-18,420,000 |
| Change In Receivables | $-1,731,000 | $-5,369,000 | $-14,776,000 | $-10,964,000 |
| Changes In Account Receivables | $-1,731,000 | $-5,369,000 | $-14,776,000 | $-10,964,000 |
| Other Non Cash Items | $4,879,000 | $3,864,000 | $-10,012,000 | $-2,750,000 |
| Stock Based Compensation | $14,164,000 | $16,356,000 | $23,221,000 | $27,536,000 |
| Asset Impairment Charge | $5,018,000 | $165,543,000 | $149,713,000 | $312,107,000 |
| Deferred Tax | $65,854,000 | $-32,659,000 | $-4,643,000 | $-34,931,000 |
| Deferred Income Tax | $65,854,000 | $-32,659,000 | $-4,643,000 | $-34,931,000 |
| Depreciation Amortization Depletion | $65,993,000 | $69,304,000 | $57,725,000 | $44,949,000 |
| Depreciation And Amortization | $65,993,000 | $69,304,000 | $57,725,000 | $44,949,000 |
| Depreciation | $65,993,000 | $69,304,000 | $57,725,000 | $44,949,000 |
| Gain Loss On Investment Securities | $72,000 | $500,000 | $3,431,000 | $-17,593,000 |
| Net Foreign Currency Exchange Gain Loss | $-1,039,000 | $303,000 | $-940,000 | $730,000 |
| Gain Loss On Sale Of PPE | $683,000 | $-13,000 | $2,635,000 | $0 |
| Net Income From Continuing Operations | $-60,489,000 | $-179,852,000 | $-215,843,000 | $-296,834,000 |
| Sale Of Business | - | - | $0 | $69,000 |
| Change In Other Current Assets | - | - | $-4,512,000 | $-6,215,000 |
Fetched: 2026-02-02